Toward isozyme-selective inhibitors of histone deacetylase as therapeutic agents for the treatment of cancer

Pharmaceutical patent analyst

Volumn 1, Issue 2, 2012, Pages 207-221

  Ononye, Sophia N ^a   van Heyst, Michael ^a   Falcone, Eric M ^a   Anderson, Amy C ^a   Wright, Dennis L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; ISOENZYME;

ANIMAL; DRUG DESIGN; DRUG EFFECTS; ENZYMOLOGY; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PATENT; PROTEIN PROCESSING;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DESIGN; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; ISOENZYMES; MOLECULAR TARGETED THERAPY; NEOPLASMS; PATENTS AS TOPIC; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84879037585     PISSN: None     EISSN: 20468962     Source Type: Journal    
DOI: 10.4155/ppa.12.21     Document Type: Review

References (0)